AUD 1.33
(-3.64%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 16.4 Thousand AUD | 0.0% |
2023 | - AUD | 0.0% |
2022 | - AUD | 0.0% |
2021 | - AUD | 0.0% |
2020 | - AUD | 100.0% |
2019 | -610.00 AUD | -41.86% |
2018 | -430.00 AUD | 76.31% |
2017 | -1815.00 AUD | 98.35% |
2016 | -109.8 Thousand AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
2013 | - AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 FY | - AUD | 0.0% |
2024 Q2 | 1.00 AUD | 0.0% |
2024 Q4 | 16.4 Thousand AUD | 0.0% |
2023 Q2 | - AUD | 0.0% |
2023 Q4 | - AUD | 0.0% |
2023 FY | - AUD | 0.0% |
2022 Q4 | - AUD | 0.0% |
2022 Q2 | 1.00 AUD | 0.0% |
2022 FY | - AUD | 0.0% |
2021 Q2 | 1.00 AUD | 0.0% |
2021 Q4 | - AUD | 0.0% |
2021 FY | - AUD | 0.0% |
2020 Q2 | - AUD | 0.0% |
2020 FY | - AUD | 100.0% |
2020 Q4 | - AUD | 0.0% |
2019 FY | -610.00 AUD | -41.86% |
2019 Q4 | -610.00 AUD | 0.0% |
2019 Q2 | - AUD | 0.0% |
2018 FY | -430.00 AUD | 76.31% |
2018 Q2 | - AUD | 0.0% |
2018 Q4 | -430.00 AUD | 0.0% |
2017 Q4 | -1815.00 AUD | 0.0% |
2017 FY | -1815.00 AUD | 98.35% |
2017 Q2 | - AUD | 0.0% |
2016 FY | -109.8 Thousand AUD | 0.0% |
2016 Q4 | - AUD | 0.0% |
2016 Q2 | - AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2015 Q1 | - AUD | 0.0% |
2015 Q3 | - AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
EZZ Life Science Holdings Limited | 1.4 Million AUD | 98.829% |
Anatara Lifesciences Ltd | -671.09 Thousand AUD | 102.444% |
Zelira Therapeutics Limited | 1.25 Million AUD | 98.69% |
Biome Australia Limited | 1.88 Million AUD | 99.132% |
Patrys Limited | - AUD | -Infinity% |
Orthocell Limited | 1.17 Million AUD | 98.606% |
Imugene Limited | - AUD | -Infinity% |
Noxopharm Limited | -2.35 Million AUD | 100.695% |
PYC Therapeutics Limited | -17.99 Million AUD | 100.091% |
Chimeric Therapeutics Limited | - AUD | -Infinity% |
Prescient Therapeutics Limited | - AUD | -Infinity% |
Proteomics International Laboratories Limited | - AUD | -Infinity% |
Cynata Therapeutics Limited | 108.2 Thousand AUD | 84.843% |
CSL Limited | 8.93 Billion AUD | 100.0% |
Arovella Therapeutics Limited | - AUD | -Infinity% |
Bio-Gene Technology Limited | - AUD | -Infinity% |
Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 99.846% |
Starpharma Holdings Limited | 2.4 Million AUD | 99.319% |
Nanollose Limited | - AUD | -Infinity% |
Memphasys Limited | 164.76 Thousand AUD | 90.046% |
Invex Therapeutics Ltd | -94.98 Thousand AUD | 117.267% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
Amplia Therapeutics Limited | - AUD | -Infinity% |
Botanix Pharmaceuticals Limited | 1.2 Million AUD | 98.644% |
Island Pharmaceuticals Limited | -877.24 Thousand AUD | 101.87% |
Nyrada Inc. | - AUD | -Infinity% |
Telix Pharmaceuticals Limited | 17.31 Million AUD | 99.905% |
Dimerix Limited | - AUD | -Infinity% |
PharmAust Limited | - AUD | -Infinity% |
Immutep Limited | 2.00 AUD | -819950.0% |
Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
Alterity Therapeutics Limited | 1.00 AUD | -1640000.0% |
BTC Health Limited | - AUD | -Infinity% |
Acrux Limited | 147 Thousand AUD | 88.843% |
Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
Biotron Limited | - AUD | -Infinity% |
Tissue Repair Ltd | 214.72 Thousand AUD | 92.362% |
AdAlta Limited | -1.67 Million AUD | 100.977% |
Radiopharm Theranostics Limited | -987.41 Thousand AUD | 101.661% |
Hexima Limited | - AUD | -Infinity% |
AnteoTech Limited | 221.85 Thousand AUD | 92.607% |
Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
Avecho Biotechnology Limited | 97.11 Thousand AUD | 83.112% |
Actinogen Medical Limited | 108.82 Thousand AUD | 84.93% |
Immuron Limited | 1.58 Million AUD | 98.965% |
Argenica Therapeutics Limited | - AUD | -Infinity% |